Skip to content
37

ketoconazol creme

Skip it

A concentrated shelf (top 5 take 100% of clicks) — this niche doesn't clear our bar today.

Market size 15Growth 35Conversion 95Competition 0Returns 100Price range 17Avg price 47Brand share 0Review moat 38Quality gap 50

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Conversion

Incredible12.5%

search→purchase rate — share of searches ending in a sale

Quality gap

Good4.5★

avg incumbent rating — lower means beatable quality

Avg price

Okay€11.60

avg listing price — sweet spot $15–$100

Review moat

Okay2,684.75

avg incumbent reviews — the moat a new listing must climb

Growth

Okay+8.1%

90-day search growth — must beat 0% to launch

Price range

Bad€8.30–€16.41

cheapest to priciest tracked listing — scored on the share inside $15–$100

Market size

Bad€61K

€61K/yr · 42K searches

Competition

Bad100%

top-5 click share — a locked-up shelf

Brand share

Bad100%

top-5 brand share — brand-locked demand

Competition

The top 5 products capture 100% of clicks — a locked-up shelf that new listings rarely crack.

Brands

3 falling

Sellers

24

Top-5 brand share

100%

Open market

0%

  • Nizoral73%
  • TERZOLIN22%
  • Ketozolin5%
  • Open — no brand owns it (0%)

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%15%€9K30%€18K45%€28K60%€37K1001K10K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 4 tracked products in this niche — three views at once, no toggling.

Demand

Weekly Amazon search volume, last 17 weeks — +8.1% search growth over the last 90 days.
4K3KSpike '26Mar '26Mar '26Apr '26Apr '26May '26May '26Jun '26Jun '26Jul '26